# Pedestal Health

> Pedestal Health delivers regulatory-grade real-world evidence for life sciences across hepatology, dermatology, and gastroenterology.

## Markdown access

Append .md to any page URL for a markdown version. Pages: `/{slug}.md`; Articles: append .md to article URLs; Team: `/people/{slug}.md`.

## Key pages

- [Home](https://www.pedestalhealth.com/index.md): Home page
- [Pedestal Health](https://www.pedestalhealth.com/index.md)
- [Privacy Policy](https://www.pedestalhealth.com/privacy-policy.md)
- [Search](https://www.pedestalhealth.com/search.md)
- [About Us](https://www.pedestalhealth.com/about.md)
- [Health Systems](https://www.pedestalhealth.com/health-systems.md)
- [Use of glucagon-like peptide 1 receptor agonists in patients with MASLD in a real-world setting is associated with slower disease progression and lower all-cause mortality](https://www.pedestalhealth.com/resources/publications/oral-presentation/use-of-glucagon-like-peptide-1-receptor-agonists-in.md)
- [Non-alcoholic Steatohepatitis Disease Progression in Participants from the United States TARGET-NASH Real World Longitudinal Observational Study](https://www.pedestalhealth.com/resources/publications/oral-presentation/non-alcoholic-steatohepatitis-disease-progression-in.md)
- [Clinical Profile of Nonalcoholic Fatty Liver Disease in Adults with Type 2 Diabetes Mellitus](https://www.pedestalhealth.com/resources/publications/oral-presentation/clinical-profile-of-nonalcoholic-fatty-liver-disease-in.md)

## Optional

- [Markdown index](https://www.pedestalhealth.com/markdown-index.txt): Complete list of all pages available in markdown format
- [Site information](https://www.pedestalhealth.com/site-info.md): Factual summary of site content (counts, lists) for support and AI